한빛사논문
- 조회466
Gun Hee Cho1,2†, Hyun Cheol Bae2†, Won Young Cho2, Eui Man Jeong3, Hee Jung Park2, Ha Ru Yang2, Sun Young Wang2, You Jung Kim2, Dong Myung Shin4, Hyung Min Chung5, In Gyu Kim6 and Hyuk‑Soo Han1,2*
1Department of Orthopedic Surgery, College of Medicine, Seoul National University, 101 Daehak‑Ro, Jongno‑Gu, Seoul 03080, Republic of Korea.
2Department of Orthopedic Surgery, Seoul National University Hospital, Yongondong Chongnogu, Seoul 110‑744, Republic of Korea.
3Department of Pharmacy, College of Pharmacy, Jeju National University, Jeju Special Self-Governing Province, Jeju‑do, Republic of Korea.
4Department of Biomedical Sciences, Asan Medical Center, University of Ulsan College of Medicine, 88 Olymic‑Ro 43‑Gil, Songpa‑Gu, Seoul 05505, Republic of Korea.
5Department of Stem Cell Biology, School of Medicine, Konkuk University, Seoul 05029, Republic of Korea.
6Laboratory for Cellular Response to Oxidative Stress, Cell2in, Inc, Seoul 03127, Republic of Korea.
†Gun Hee Cho and Hyun Cheol Bae contributed equally to this work.
*Correspondence: Hyuk‑Soo Han
Abstract
Background: Mesenchymal stem cells (MSCs) are a promising cell source for cartilage regeneration. However, the function of MSC can vary according to cell culture conditions, donor age, and heterogeneity of the MSC population, resulting in unregulated MSC quality control. To overcome these limitations, we previously developed a fluorescent real-time thiol tracer (FreSHtracer) that monitors cellular levels of glutathione (GSH), which are known to be closely associated with stem cell function. In this study, we investigated whether using FreSHtracer could selectively separate high-functioning MSCs based on GSH levels and evaluated the chondrogenic potential of MSCs with high GSH levels to repair cartilage defects in vivo.
Methods: Flow cytometry was conducted on FreSHtracer-loaded MSCs to select cells according to their GSH levels. To determine the function of FreSHtracer-isolated MSCs, mRNA expression, migration, and CFU assays were conducted. The MSCs underwent chondrogenic differentiation, followed by analysis of chondrogenic-related gene expression. For in vivo assessment, MSCs with different cellular GSH levels or cell culture densities were injected in a rabbit chondral defect model, followed by histological analysis of cartilage-regenerated defect sites.
Results: FreSHtracer successfully isolated MSCs according to GSH levels. MSCs with high cellular GSH levels showed enhanced MSC function, including stem cell marker mRNA expression, migration, CFU, and oxidant resistance. Regardless of the stem cell tissue source, FreSHtracer selectively isolated MSCs with high GSH levels and high functionality. The in vitro chondrogenic potential was the highest in pellets generated by MSCs with high GSH levels, with increased ECM formation and chondrogenic marker expression. Furthermore, the MSCs' function was dependent on cell culture conditions, with relatively higher cell culture densities resulting in higher GSH levels. In vivo, improved cartilage repair was achieved by articular injection of MSCs with high levels of cellular GSH and MSCs cultured under high-density conditions, as confirmed by Collagen type 2 IHC, Safranin-O staining and O'Driscoll scores showing that more hyaline cartilage was formed on the defects.
Conclusion: FreSHtracer selectively isolates highly functional MSCs that have enhanced in vitro chondrogenesis and in vivo hyaline cartilage regeneration, which can ultimately overcome the current limitations of MSC therapy.
논문정보
- Research article
- 2023년 06월 (BRIC 등록일 2023-06-08)
- 국내 연구진
댓글 작성 로그인
팝업 닫기관련 링크
연구자 ID
관련분야 연구자보기
소속기관 논문보기
관련분야 논문보기
해당논문 저자보기
